Nagisa Hanawa

752 citations

37 papers · 507 indexed · h-index 15

Epidemiology top 10%
Endocrinology, Diabetes and Metabolism top 5%
Surgery
Pathology and Forensic Medicine
Hepatology top 10%

Co-authors: Marenao Tanaka Masato Furuhashi Hirofumi Ohnishi Kazuma Mori Yukimura Higashiura Tetsuji Miura Norihito Moniwa Masayuki Koyama
Topics: Liver Disease Diagnosis and Treatment (22 papers)Alcohol Consumption and Health Effects (10 papers)Diet, Metabolism, and Disease (9 papers)
Cited by: Endocrinology, Diabetes and Metabolism Hepatology Nephrology
Journals: SHILAP Revista de lepidopterologíaDiabetes Scientific Reports
Partner nations: Japan Taiwan United States

In The Last Decade

Nagisa Hanawa

34 papers receiving 502 citations

Peers

Countries citing papers authored by Nagisa Hanawa

Since Specialization

Citations

This map shows the geographic impact of Nagisa Hanawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nagisa Hanawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nagisa Hanawa more than expected).

Fields of papers citing papers by Nagisa Hanawa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nagisa Hanawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nagisa Hanawa. The network helps show where Nagisa Hanawa may publish in the future.

Co-authorship network of co-authors of Nagisa Hanawa

This figure shows the co-authorship network connecting the top 25 collaborators of Nagisa Hanawa. A scholar is included among the top collaborators of Nagisa Hanawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nagisa Hanawa. Nagisa Hanawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	High Level of Estimated Small Dense Low-Density Lipoprotein Cholesterol as an Independent Risk Factor for the Development of Ischemic Heart Disease Regardless of Low-Density Lipoprotein Cholesterol Level　― A 10-Year Cohort Study ― 2025 ·Circulation Journal ·(unknown),Marenao Tanaka,Tatsuya Sato,(unknown),Kei Nakata,(unknown),(unknown),(unknown),Yukinori Akiyama,Nagisa Hanawa,Masato Furuhashi	2
2	Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Is an Independent Risk Factor for the Development of Ischemic Heart Disease　― A 10-Year Cohort Study ― 2025 ·Circulation Reports ·(unknown),Tatsuya Sato,Marenao Tanaka,Yukinori Akiyama,Kei Nakata,Hidemichi Kouzu,Kazuma Mori,(unknown),(unknown),(unknown),Toru Suzuki,Nagisa Hanawa,Masato Furuhashi	2
3	Elevated level of estimated small dense LDL cholesterol is independently associated with the development of hypertension, regardless of LDL cholesterol level 2025 ·Hypertension Research ·(unknown),Marenao Tanaka,Tatsuya Sato,(unknown),Rie Matsumori,(unknown),Yukinori Akiyama,Kei Nakata,Hidemichi Kouzu,Nagisa Hanawa,(unknown)	0
4	Deciphering metabolic dysfunction‐associated steatotic liver disease: insights from predictive modeling and clustering analysis 2024 ·Journal of Gastroenterology and Hepatology ·Kazuma Mori,Yukinori Akiyama,Marenao Tanaka,Tatsuya Sato,(unknown),(unknown),Nagisa Hanawa,Naoya Sakamoto,Masato Furuhashi	12
5	Metabolic dysfunction‐associated steatotic liver disease (SLD) and alcohol‐associated liver disease, but not SLD without metabolic dysfunction, are independently associated with new onset of chronic kidney disease during a 10‐year follow‐up period 2024 ·Hepatology Research ·Kazuma Mori,Marenao Tanaka,Tatsuya Sato,Yukinori Akiyama,(unknown),(unknown),Toru Suzuki,(unknown),(unknown),Kei Nakata,(unknown),(unknown),Nagisa Hanawa,Masato Furuhashi	14
6	Predictive modeling for the development of diabetes mellitus using key factors in various machine learning approaches 2023 ·SHILAP Revista de lepidopterología ·Marenao Tanaka,Yukinori Akiyama,Kazuma Mori,(unknown),Kenichi Kato,(unknown),(unknown),Tatsuya Sato,Toru Suzuki,Toshiyuki Yano,Hirofumi Ohnishi,Nagisa Hanawa,Masato Furuhashi	10
7	Calculated Small Dense Low-Density Lipoprotein Cholesterol Level is A Predominant Predictor for New Onset of Ischemic Heart Disease 2023 ·Journal of Atherosclerosis and Thrombosis ·(unknown),Marenao Tanaka,Tatsuya Sato,(unknown),Kazuma Mori,(unknown),(unknown),(unknown),Hirofumi Ohnishi,Yukinori Akiyama,Nagisa Hanawa,Masato Furuhashi	9
8	An increase in calculated small dense low-density lipoprotein cholesterol predicts new onset of hypertension in a Japanese cohort 2023 ·Hypertension Research ·Marenao Tanaka,Tatsuya Sato,(unknown),(unknown),Kazuma Mori,(unknown),(unknown),Yukinori Akiyama,Hirofumi Ohnishi,Nagisa Hanawa,Masato Furuhashi	11
9	Coexistence of Metabolic Dysfunction‐Associated Fatty Liver Disease and Chronic Kidney Disease Is a More Potent Risk Factor for Ischemic Heart Disease 2023 ·Journal of the American Heart Association ·(unknown),Marenao Tanaka,Tatsuya Sato,(unknown),Kazuma Mori,(unknown),(unknown),Nagisa Hanawa,Hirofumi Ohnishi,Masato Furuhashi	20
10	A high level of thyroid-stimulating hormone is a risk factor for the development of chronic kidney disease in men: a 10-year cohort study 2023 ·Hypertension Research ·(unknown),Marenao Tanaka,Tatsuya Sato,Kazuma Mori,(unknown),(unknown),(unknown),Yukinori Akiyama,Hirofumi Ohnishi,Nagisa Hanawa,Masato Furuhashi	3
11	Metabolic dysfunction-associated fatty liver disease is associated with an increase in systolic blood pressure over time: linear mixed-effects model analyses 2023 ·Hypertension Research ·Kazuma Mori,Marenao Tanaka,(unknown),(unknown),(unknown),Nagisa Hanawa,Hirofumi Ohnishi,Masato Furuhashi	14
12	Fatty liver index is independently associated with deterioration of renal function during a 10-year period in healthy subjects 2021 ·Scientific Reports ·Satoko Takahashi,Marenao Tanaka,Masato Furuhashi,Norihito Moniwa,Masayuki Koyama,Yukimura Higashiura,(unknown),(unknown),Hirofumi Ohnishi,(unknown),(unknown),Nagisa Hanawa,Tetsuji Miura	28
13	High level of fatty liver index predicts new onset of diabetes mellitus during a 10-year period in healthy subjects 2021 ·Scientific Reports ·Yukimura Higashiura,Masato Furuhashi,Marenao Tanaka,Satoko Takahashi,Masayuki Koyama,Hirofumi Ohnishi,(unknown),(unknown),Nagisa Hanawa,Norihito Moniwa,Kazufumi Tsuchihashi,Tetsuji Miura	27
14	A Deep Learning Architecture for Vascular Area Measurement in Fundus Images 2021 ·SHILAP Revista de lepidopterología ·(unknown),Michiyuki Saito,Kousuke Noda,Miyuki Murata,Satoru Kase,(unknown),Naoki Isogai,(unknown),Nagisa Hanawa,Mitsuru Dohke,Manabu Kase,Susumu Ishida	14
15	Serum uric acid level is associated with an increase in systolic blood pressure over time in female subjects: Linear mixed-effects model analyses 2021 ·Hypertension Research ·Kazuma Mori,Masato Furuhashi,Marenao Tanaka,Yukimura Higashiura,Masayuki Koyama,Nagisa Hanawa,Hirofumi Ohnishi	10
16	U-shaped relationship between serum uric acid level and decline in renal function during a 10-year period in female subjects: BOREAS-CKD2 2020 ·Hypertension Research ·Kazuma Mori,Masato Furuhashi,Marenao Tanaka,(unknown),(unknown),Nagisa Hanawa,Masayuki Koyama,(unknown),Yukimura Higashiura,(unknown),Megumi Matsumoto,Norihito Moniwa,Hirofumi Ohnishi,Tetsuji Miura	33
17	Inverse Association Between Fatty Liver at Baseline Ultrasonography and Remission of Type 2 Diabetes Over a 2-Year Follow-up Period 2020 ·Clinical Gastroenterology and Hepatology ·Hajime Yamazaki,Jui Wang,(unknown),Mitsuru Dohke,Nagisa Hanawa,Akio Katanuma,Yoshifumi Saisho,Tsukasa Kamitani,Shunichi Fukuhara,Yosuke Yamamoto	7
18	Longitudinal association of fatty pancreas with the incidence of type-2 diabetes in lean individuals: a 6-year computed tomography-based cohort study 2020 ·Journal of Gastroenterology ·Hajime Yamazaki,(unknown),Jui Wang,Mitsuru Dohke,Nagisa Hanawa,Yoshihisa Kodama,Akio Katanuma,Yoshifumi Saisho,Tsukasa Kamitani,Shunichi Fukuhara,Yosuke Yamamoto	30
19	Insulin Resistance is Associated with Longitudinal Changes of Cardiac Repolarization Heterogeneity in Apparently Healthy Subjects 2019 ·Cardiology and Therapy ·Tamaki Matsumoto,Hirofumi Ohnishi,Tatsuya Sato,Takayuki Miki,Hiroshi Akasaka,Nagisa Hanawa,Masayuki Koyama,Shigeyuki Saitoh,Tetsuji Miura	10
20	The impact of elevation of serum uric acid level on the natural history of glomerular filtration rate (GFR) and its sex difference 2014 ·Nephrology Dialysis Transplantation ·Hiroshi Akasaka,(unknown),Hideki Takizawa,Nagisa Hanawa,(unknown),Marenao Tanaka,Norihito Moniwa,Nobuhiko Togashi,Tomohisa Yamashita,Setsuko Kuroda,Nobuyuki Ura,Tetsuji Miura,(unknown)	30

About Nagisa Hanawa

Nagisa Hanawa is a scholar working on Endocrinology, Diabetes and Metabolism, Hepatology and Nephrology, having authored 37 papers that have together received 507 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (22 papers), Alcohol Consumption and Health Effects (10 papers) and Diet, Metabolism, and Disease (9 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (211 citations), Hepatology (92 citations) and Nephrology (78 citations). Nagisa Hanawa has collaborated with scholars based in Japan, Taiwan and United States. Frequent co-authors include Marenao Tanaka, Masato Furuhashi, Hirofumi Ohnishi, Kazuma Mori, Yukimura Higashiura, Tetsuji Miura, Norihito Moniwa, Masayuki Koyama, Satoko Takahashi and Mitsuru Dohke. Their work appears in journals such as SHILAP Revista de lepidopterología, Diabetes and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact